Pyrroline-5-carboxylate reductase 1 (PYCR1), a well-documented tumor promoting factor, attracted our attention since it was reported to be dysregulated in bladder cancer and might be participated in regulating PI3K/AKT pathway [25]. This evidence concerns the gene AKT1 and urinary bladder cancer.